Gene · 3818
Papers2,245
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,245
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain. | Invest Ophthalmol Vis Sci | 2023 | 36820679 | PubTator, text mining | PubMed |
| KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study. | Atherosclerosis | 2023 | 36812656 | PubTator, text mining | PubMed |
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
| An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial. | Lancet | 2023 | 36774155 | PubTator, text mining | PubMed |
| Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation. | Hypertension | 2023 | 36756872 | PubTator, text mining | PubMed |
| Iripin-1, a new anti-inflammatory tick serpin, inhibits leukocyte recruitment in vivo while altering the levels of chemokines and adhesion molecules. | Front Immunol | 2023 | 36756125 | Swiss-Prot, curated | PubMed |
| Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins. | Front Endocrinol (Lausanne) | 2023 | 36733527 | PubTator, text mining | PubMed |
| 6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors. | Cardiovasc Hematol Agents Med Chem | 2023 | 36703578 | PubTator, text mining | PubMed |
| Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence. | J Thromb Haemost | 2023 | 36700498 | PubTator, text mining | PubMed |
| Titanium is a potent inducer of contact activation: implications for intravascular devices. | J Thromb Haemost | 2023 | 36696212 | PubTator, text mining | PubMed |
| Human osteoarthritis knee joint synovial fluids cleave and activate Proteinase-Activated Receptor (PAR) mediated signaling. | Sci Rep | 2023 | 36670151 | PubTator, text mining | PubMed |
| The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study. | Clin Proteomics | 2023 | 36650427 | PubTator, text mining | PubMed |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | 36648960 | PubTator, text mining | PubMed |
| [Analysis of differentially expressed microRNA and protein expression profiles carried by exosomes in the plasma of patients with Takayasu's arteritis]. | Zhonghua Nei Ke Za Zhi | 2023 | 36631039 | PubTator, text mining | PubMed |
| Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. | Adv Ther | 2023 | 36609679 | PubTator, text mining | PubMed |
| Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative. | World Allergy Organ J | 2023 | 36601261 | PubTator, text mining | PubMed |
| Microbial pathways in the coupling of iron, sulfur, and phosphorus cycles at the sediment-water interface of a river system: An in situ study involving the DGT technique. | Sci Total Environ | 2023 | 36535485 | PubTator, text mining | PubMed |
| Let's talk about sexuality - A web-based survey of self-reported competence in sexual problems among obstetrician-gynecologists in Finland. | Acta Obstet Gynecol Scand | 2023 | 36515100 | PubTator, text mining | PubMed |
| Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit. | Allergy | 2023 | 36510404 | PubTator, text mining | PubMed |
| Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. | Clin Cancer Res | 2023 | 36508165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3818/papers?page=13